Evidence map›Paper›PMID 30277610›Full record

ArticleThe Milbank quarterly2018

Systems Thinking as a Framework for Analyzing Commercial Determinants of Health.

Cécile Knai, Mark Petticrew, Nicholas Mays, Simon Capewell, Rebecca Cassidy, Steven Cummins, Elizabeth Eastmure, Patrick Fafard, Benjamin Hawkins, Jørgen Dejgård Jensen and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Milbank quarterly, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 4 pooled it
32.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 4 syntheses or guidelines pooled it, 203 citations in OpenAlex.

  1. Pooled it
  2. Commercial determinants of health: an ethical exploration.International journal of public health · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 4 countries.

Cécile KnaiLondon School of Hygiene and Tropical Medicine.
Mark PetticrewLondon School of Hygiene and Tropical Medicine.
Nicholas MaysLondon School of Hygiene and Tropical Medicine.
Simon CapewellUniversity of Liverpool.
Rebecca CassidyGoldsmiths, University of London.
Steven CumminsLondon School of Hygiene and Tropical Medicine.
Elizabeth EastmureLondon School of Hygiene and Tropical Medicine.
Patrick FafardUniversity of Ottawa.
Benjamin HawkinsLondon School of Hygiene and Tropical Medicine.
Jørgen Dejgård JensenUniversity of Copenhagen.
Srinivasa Vittal KatikireddiUniversity of Glasgow.
Modi MwatsamaUK Health Forum.
Jim OrfordUniversity of Birmingham.
Heide WeishaarHertie School of Governance.
London School of Hygiene & Tropical Medicine · GBGoldsmiths University of London · GBHertie School · DEUK Health Forum · GBUniversity of Birmingham · GBUniversity of Copenhagen · DKUniversity of Glasgow · GBUniversity of Liverpool · GBUniversity of Ottawa · CA

Funding

Chief Scientist Office SCAF/15/02Chief Scientist Office SPHSU13Chief Scientist Office SPHSU15Medical Research Council G0900847Medical Research Council MC_UU_12017/13Medical Research Council MC_UU_12017/15
6 · The paper itself

Abstract

Policy Points: Worldwide, more than 70% of all deaths are attributable to noncommunicable diseases (NCDs), nearly half of which are premature and apply to individuals of working age. Although such deaths are largely preventable, effective solutions continue to elude the public health community. One reason is the considerable influence of the "commercial determinants of health": NCDs are the product of a system that includes powerful corporate actors, who are often involved in public health policymaking. This article shows how a complex systems perspective may be used to analyze the commercial determinants of NCDs, and it explains how this can help with (1) conceptualizing the problem of NCDs and (2) developing effective policy interventions. CONTEXT: The high burden of noncommunicable diseases (NCDs) is politically salient and eminently preventable. However, effective solutions largely continue to elude the public health community. Two pressing issues heighten this challenge: the first is the public health community's narrow approach to addressing NCDs, and the second is the involvement of corporate actors in policymaking. While NCDs are often conceptualized in terms of individual-level risk factors, we argue that they should be reframed as products of a complex system. This article explores the value of a systems approach to understanding NCDs as an emergent property of a complex system, with a focus on commercial actors.

methodsDrawing on Donella Meadows's systems thinking framework, this article examines how a systems perspective may be used to analyze the commercial determinants of NCDs and, specifically, how unhealthy commodity industries influence public health policy.

findingsUnhealthy commodity industries actively design and shape the NCD policy system, intervene at different levels of the system to gain agency over policy and politics, and legitimize their presence in public health policy decisions.

conclusionsIt should be possible to apply the principles of systems thinking to other complex public health issues, not just NCDs. Such an approach should be tested and refined for other complex public health challenges.

Indexed as

CommerceSocial Determinants of HealthSystems AnalysisHealth PolicyHumansNoncommunicable DiseasesPolicy MakingPublic Health Practicenoncommunicable diseasessystems thinkingunhealthy commodity industries

Identifiers

PMID30277610
PMCPMC6131339
OpenAlexW2885787595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.